121 related articles for article (PubMed ID: 8468438)
1. A randomized, double-blind, multi-centre, parallel-group study comparing the tolerability and efficacy of moclobemide and dothiepin hydrochloride in depressed patients in general practice.
Beaumont G; Gringras M; Hobbs FD; Drury VW; Freeling P; Tylee A; Shanley DF; Comber H; Little S; Hill S
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):159-65. PubMed ID: 8468438
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners.
Gachoud JP; Dick P; Köhler M
Clin Neuropharmacol; 1994; 17 Suppl 1():S29-37. PubMed ID: 7954482
[TBL] [Abstract][Full Text] [Related]
3. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
Duarte A; Mikkelsen H; Delini-Stula A
J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
[TBL] [Abstract][Full Text] [Related]
4. Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study.
Rimón R; Jääskeläinen J; Kaartinen P; Kalli A; Kilponen E; Koskinen T; Nikkilä H; Pirttiperä V; Seppälä J
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):141-7. PubMed ID: 8468435
[TBL] [Abstract][Full Text] [Related]
5. Multicenter double-blind study of moclobemide and maprotiline.
Vaz-Serra A; Figueira ML; Firmino H; Albuquerque AJ; Jara JM; Pestana LC
Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483
[TBL] [Abstract][Full Text] [Related]
6. Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial.
Roth M; Mountjoy CQ; Amrein R
Br J Psychiatry; 1996 Feb; 168(2):149-57. PubMed ID: 8837903
[TBL] [Abstract][Full Text] [Related]
7. Moclobemide versus fluoxetine for a major depressive episode.
Reynaert C; Parent M; Mirel J; Janne P; Haazen L
Psychopharmacology (Berl); 1995 Mar; 118(2):183-7. PubMed ID: 7617806
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice.
Doogan DP; Langdon CJ
Int Clin Psychopharmacol; 1994; 9(2):95-100. PubMed ID: 8057000
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression.
Stabl M; Kasas A; Blajev B; Bajetta G; Zöchling R; Holsboer-Trachsler E; Realini R; Schäublin-Loidl M
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):41S-45S. PubMed ID: 7593730
[TBL] [Abstract][Full Text] [Related]
10. Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study.
Kragh-Sørensen P; Müller B; Andersen JV; Buch D; Stage KB
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):24S-30S. PubMed ID: 7593726
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or in three divided doses per day for the treatment of patients with a major depressive episode (DSM-III-R).
Newburn G; Edwards R; Thomas H; Collier J; Fox K; Collins C; Cramer D; Reeves J; Caracatsanis A
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):10S-15S. PubMed ID: 7593724
[TBL] [Abstract][Full Text] [Related]
12. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
[TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of moclobemide and tranylcypromine in depression.
Heinze G; Rossel L; Gabelic I; Galeano-Munoz J; Stabl M; Allen SR
Pharmacopsychiatry; 1993 Nov; 26(6):240-5. PubMed ID: 8127928
[TBL] [Abstract][Full Text] [Related]
14. A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study Group.
Int Clin Psychopharmacol; 1994; 9(2):109-13. PubMed ID: 8056992
[TBL] [Abstract][Full Text] [Related]
15. A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders.
Williams R; Edwards RA; Newburn GM; Mullen R; Menkes DB; Segkar C
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):155-8. PubMed ID: 8468437
[TBL] [Abstract][Full Text] [Related]
16. Moclobemide and placebo in mild major depression: a double-blind randomized trial.
Ose E; Holm P
Psychopharmacology (Berl); 1992; 106 Suppl():S114-5. PubMed ID: 1546122
[TBL] [Abstract][Full Text] [Related]
17. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three-times-daily dosage schedules.
Gagiano CA; Hart GA; Bodemer W; Schall R
Clin Neuropharmacol; 1994; 17 Suppl 1():S1-8. PubMed ID: 7954480
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria.
Hebenstreit GF; Loidl M; Baumhackl U; Gallhofer B; Geretsegger C; Radmayr E; Saletu M; Schöny W; Stabl M
J Neural Transm Suppl; 1990; 32():177-84. PubMed ID: 2089087
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine.
Lonnqvist J; Sintonen H; Syvälahti E; Appelberg B; Koskinen T; Mannikko T; Mehtonen OP; Naarala M; Sihvo S; Auvinen J
Acta Psychiatr Scand; 1994 Jun; 89(6):363-9. PubMed ID: 8085464
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, comparative study of dothiepin and clomipramine in the treatment of major depressive illness.
Welch CP; Tweed JA; Smithers A; Gostick NK; Raniwalla J
Int J Clin Pract; 1997 Sep; 51(6):360-3. PubMed ID: 9489063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
